StonvexLoading…
StonvexStonvexStonvexCore line items from CMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $33.67B | $34.10B | $34.06B | $28.07B |
Operating Income | $4.03B | $3.75B | $1.76B | $2.93B |
Net Income | $2.96B | $4.07B | $840.00M | $2.18B |
EPS (Diluted) | $20.50 | $28.37 | $5.15 | $15.12 |
Total Assets | $33.99B | $31.54B | $32.01B | $30.30B |
Total Liabilities | $20.58B | $20.23B | $22.10B | $20.07B |
Cash & Equivalents | $2.85B | $1.67B | $2.18B | $2.10B |
Free Cash Flow OCF − CapEx | $2.39B | $279.00M | $2.75B | $1.05B |
Shares Outstanding | 138.70M | 139.10M | 142.70M | 142.30M |